Study of next-generation investigational HIV-1 maturation inhibitor shows positive results in preventing viral replication via different mechanism of action than current therapies
26 February 2015 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced data supporting the clinical development of BMS-955176, an investigational component designed to prevent the maturation of HIV-1...